Overview

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Status:
NOT_YET_RECRUITING
Trial end date:
2032-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Phase:
PHASE4
Details
Lead Sponsor:
University of Miami
Treatments:
testosterone 17 beta-cypionate